Charles Q Morris
CIK 1489966 · Chief Medical Officer · last filed 2026-05-04
Charles Q Morris is a Chief Medical Officer who has filed 25 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for PRLD, was dated May 4, 2026. Across all open-market trades the lifetime net is −$925.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
25
-$925.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRLD | Chief Medical Officer | — | $4.49 | — | $0 | 1 | 2026-05-04 |
| LAVA Therapeutics NV (LVTX) Delisted | Chief Medical Officer | — | $1.74 | — | $0 | 1 | 2025-02-18 |
| Radius Health, Inc. (RDUS) Delisted | Chief Medical Officer | 33,744 | $30.00 | $1.01M | -$22.5K | 4 | 2020-02-28 |
| ImmunoGen, Inc. (IMGN) Delisted | Executive VP & CDO | 27,090 | $31.23 | $846.0K | -$774.2K | 10 | 2016-07-20 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Chief Medical Officer | 0 | — | — | -$128.6K | 9 | 2012-09-05 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-04 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | LAVA Therapeutics NV (LVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-28 | Radius Health, Inc. (RDUS) Delisted | Sell (S) | −1,256 | -$22.5K | EDGAR |
| 2020-02-24 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2019-02-26 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2018-09-05 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-20 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-30 | ImmunoGen, Inc. (IMGN) Delisted | Sell (S) | −5,170 | -$72.4K | EDGAR |
| 2015-07-14 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-02 | ImmunoGen, Inc. (IMGN) Delisted | Sell (S) | −5,240 | -$54.5K | EDGAR |